Alligator Bioscience
BioStock: Phase II results indicate durability of response for Alligator's CD40 agonist
Read the interview with Sumeet Ambarkhane at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/
Datum | 2023-06-30, kl 11:46 |
Källa | Cision |

Copy Trading innebär inte investeringsrådgivning. Värdet på dina investeringar kan gå upp eller ner. Du riskerar ditt kapital.